September 24, 2020
Dr. Katherine Burns' experience with endometriosis fuels her research to find a cure for a disease that affects one in 10 women. The University of Cincinnati researcher was recently awarded a five-year $2.1 million grant from the National Institutes of Health to look more closely at how the immune system may play a role in the development of endometriosis.
September 22, 2020
Drugs.com covers UC research looking at mortality in patients with cancer and COVID-19.
September 22, 2020
Researchers at the University of Cincinnati and UC Health will host a Phase 2 clinical trial (NCT04511650) to examine the effects of a drug that targets blood vessel inflammation and injury in patients with COVID-19. They will study the effects of razuprotafib, an investigational drug that activates a key pathway for stabilizing blood vessels in the lung and other organs in patients with moderate to severe cases of the respiratory illness caused by the novel coronavirus SARS-CoV-2. The drug may prevent and treat respiratory distress in COVID-19 patients. The Phase 2 clinical trial will assess safety, tolerability and efficacy of razuprotafib.
September 24, 2020
Dr. Katherine Burns' experience with endometriosis fuels her research to find a cure for a disease that affects one in 10 women. The University of Cincinnati researcher was recently awarded a five-year $2.1 million grant from the National Institutes of Health to look more closely at how the immune system may play a role in the development of endometriosis.
September 22, 2020
Drugs.com covers UC research looking at mortality in patients with cancer and COVID-19.
September 22, 2020
Researchers at the University of Cincinnati and UC Health will host a Phase 2 clinical trial (NCT04511650) to examine the effects of a drug that targets blood vessel inflammation and injury in patients with COVID-19. They will study the effects of razuprotafib, an investigational drug that activates a key pathway for stabilizing blood vessels in the lung and other organs in patients with moderate to severe cases of the respiratory illness caused by the novel coronavirus SARS-CoV-2. The drug may prevent and treat respiratory distress in COVID-19 patients. The Phase 2 clinical trial will assess safety, tolerability and efficacy of razuprotafib.
September 22, 2020
WVXU reports on a University of Cincinnati study showing cancer patients undergoing a combination of chemotherapy and immunotherapy one to three months before a COVID-19 diagnosis have a greater risk of death than patients who haven't undergone cancer treatment in the past year.
September 21, 2020
Newly appointed associate dean Dr. Tim Le Cras answers questions about leading the College of Medicine's graduate programs.
September 19, 2020
University of Cincinnati researchers have found that certain treatments for cancer may increase the chance of death if they contract COVID-19.
September 17, 2020
Early in the onset of the COVID-19 pandemic, a small study in China produced results that influenced subsequent research on the virus. Researchers at the University of Cincinnati used the same study parameters on a much larger patient population and reached completely different findings. The study was published in the journal Progress in Cardiovascular Diseases in mid-July.
September 16, 2020
Pharmacy Times highlights UC research examining the hierarchy of breast cancer cells in relation to treatment resistance.
September 15, 2020
Ahmad Sedaghat, MD, PhD, an associate professor in the University of Cincinnati College of Medicine and UC Health physician, discusses seasonal allergies with local TV stations Fox 19 and WCPO.
September 14, 2020
Neurosciences graduate student Jennifer Patritti Cram has received a Young Investigator Award from the Children’s Tumor Foundation
September 14, 2020
Carl Fichtenbaum, MD, was interviewed by CNN for a story they published about a delay in the Astra-Zeneca COVID-19 vaccine trial.
September 11, 2020
If you have itchy puffy eyes and a nasal drip that just won’t quit, you might be one of more than 23 million Americans with ragweed allergies. This troublesome weed is making life miserable for many as the seasons change. A University of Cincinnati ear, nose and throat experts, offers a few tips for keeping those fall allergies in check.
September 8, 2020
Five African-American researchers and healthcare professionals on UC’s medical campus have received sizable grants from the National Institutes of Health during the past 18 months. The faculty members were interviewed by WCPO to help showcase innovation and the diverse voices and perspectives they bring as the healthcare community attempts to ease health disparities in communities of color in Cincinnati and beyond.
September 3, 2020
Jarelle Marshall, the first volunteer dosed for the UC/UC Health Moderna COVID-19 vaccine trial, was interviewed by USA Today for an article on people who are taking part in COVID-19 research.
September 3, 2020
Brett Kissela, MD, participates in COVID-19 vaccine trial at UC.